SCHEMBL29944477

SCHEMBL29944477

CN(C)Cc1ccnc(Cl)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.57
LOX P28300 1/20 0.57
LOXL3 P58215 1/20 0.57
LOXL2 Q9Y4K0 1/20 0.57
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
CHRNB2 P17787 1/20 0.41
CHRNA4 P43681 1/20 0.41
ALDH1A1 P00352 2/20 0.40
TSHR P16473 2/20 0.40
HRH3 Q9Y5N1 1/20 0.40
TAAR1 Q96RJ0 2/20 0.40
GRM5 P41594 1/20 0.39
HPGD P15428 1/20 0.37
HTR1A P08908 1/20 0.37
HTR1D P28221 1/20 0.37
HTR1B P28222 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL938454 1.00 RECQL (0.57) RECQLLOXLOXL3LOXL2HDAC4
SCHEMBL17286036 0.83 RECQL (0.52) RECQLLOXLOXL3LOXL2HDAC4
SCHEMBL23358131 0.80 RECQL (0.49) RECQLLOXLOXL3LOXL2ALDH1A1
SCHEMBL17804146 0.79 RECQL (0.51) RECQLLOXLOXL3LOXL2HDAC4
SCHEMBL23358048 0.79 RECQL (0.51) RECQLLOXLOXL3LOXL2HDAC4
SCHEMBL14613356 0.78 UHRF1 (0.46) HDAC4HDAC1HDAC6CHRNB2CHRNA4
Hydrochloric Acid SCHEMBL11106783 0.77 CHRNB2 (0.39) RECQLCHRNB2CHRNA4ALDH1A1TSHR
Hydrochloric Acid SCHEMBL10393628 0.77 CHRNB2 (0.39) RECQLCHRNB2CHRNA4ALDH1A1TSHR
SCHEMBL937707 0.77
SCHEMBL805501 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114728950-B Compounds useful as inhibitors of HELIOS proteins 百时美施贵宝公司 2024-10-18 CN disclosed
EP-4061812-A1 COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN Bristol-Myers Squibb Company (US) 2022-09-28 EP disclosed